Risk factors for SARS-CoV-2 pneumonia among renal transplant recipients in Omicron pandemic—a prospective cohort study

Table 3 Logistic regression analysis of predictors of pneumonia (n = 383)

Variables	OR (95%CI)	P value
Age, years
<40 (Ref.)
40–49	2.082(1.048,4.140)	0.036
50–59	3.365(1.565,7.232)	0.002
≥ 60	2.438(0.842,7.059)	0.100
BMI ≥ 24, kg/m²
No (Ref.)
Yes
Post-Transplantation duration, years	0.924(0.866,0.986)	0.017
Post-transplant Comorbidities
Pulmonary infection history	3.437(1.459,8.099)	0.005
Post-transplant CCI	1.842(1.138,2.980)	0.013
Symptoms
Fatigue	2.111(1.143,3.902)	0.017
Cough	2.031(1.082,3.813)	0.027
eGFR at COVID-19 Diagnosis	0.983(0.970,0.995)	0.008

Abbreviations: BMI, body mass index; CCI, Charlson comorbidity index; eGFR, estimated glomerular filtration rate
Note: the following variables were not significant in the multivariable analysis and were thus not listed in the table: donor type, pre-transplant myocardial infarction, post-transplant BK nephropathy, pre-infection eGFR, post-transplant CCI, expectoration, diarrhea, anorexia, hypogeusia, shortness of breath after activity, dyspnea, immunosuppressants, NSAIDs, Nirmatrelvir/ritonavir, Azvudine, Gamma globulin, and hospitalization

ISSN: 1743-422X